Login to Your Account

Evotec Taps Chinese Market via Conba Deal for EVT 401

By Nuala Moran
Staff Writer

Wednesday, May 9, 2012
LONDON – Evotec AG landed its second out-licensing deal in China last week, taking a small up-front payment, with €60 million (US$78.8 million) to come in milestones, followed by double-digit royalties on sales if EVT 401 makes it through to Chinese marketing approval.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription